Topic List : Precision Health
D-limonene could offset dry mouth in cancer patients
A Stanford collaboration between clinical and basic science researchers has led to the identification of a compound that could improve the quality of life for head and neck cancer patients.
Center aims to stop disease before it starts
At the Precision Health and Integrated Diagnostics Center, scientists turn the norms of disease research on their head, searching not for treatments but for ways to prevent disease entirely.
PET tracer predicts success of cancer ‘vaccine’
With a radioactive tracer, scientists can use a PET scan to quickly tell whether a cancer immunotherapy will be effective or not, according to a new Stanford study.
Multigene tests for breast cancer on the rise
Tests to detect mutations in multiple genes are replacing BRCA-only analyses in women with breast cancer, according to a study by scientists at Stanford and several other institutions. Greater access to genetic counselors needed.
Special diet helps bacteria engraft in gut
Gut bacteria able to digest seaweed can outcompete native bacteria in the large intestine of nori-fed mice, according to Stanford scientists. Favoring one species over others in the gut could help advance precision health.
Protein mimic eases breathing
The material could be used to synthesize a film that coats the inner surface of lungs, possibly leading to better, cheaper treatments for acute lung injury in humans.
Brain link between obesity, depression
Reward centers in the brains of children and teenagers who are obese and depressed show abnormalities that suggest the two conditions are neurologically connected, Stanford researchers have found.
Big data conference set for May 23-24
The two-day conference will feature leaders from academia, government and industry who harness immense data sets to more precisely predict, diagnose and treat disease.
Altered immune cells attack brain tumor
In mice, a fatal brainstem tumor was cleared by injecting it with engineered T cells that recognized the cancer and targeted it for destruction. The Stanford discovery is moving to human trials.
Exome sequencing program launched
The Clinical Genomics Program, which began as a pilot program a few years ago, offers whole-exome sequencing and analysis to patients with undiagnosed genetic diseases.